Go Long On Panasonic Corporation, Enzolytics Inc Stocks, Buy Rushnet Inc Stock On Declines, Neutral On Adidas Stock

Panasonic Corporation (OTCMKTS: PCRFY) Stock Trades At $11.84

Panasonic Corporation (OTCMKTS: PCRFY) closed at $11.84 (up 3.95%) on June 25, 2021. The stock gained 6.38% in the past week. Its trend is bullish and targets $13. 

According to a communiqué on June 25, 2021, Panasonic sold its entire stake in Tesla and raised $3.6 billion. 

As of March 2020, Panasonic held $730 million in Tesla. It sold all the shares of Tesla in March 2021. The shares of Tesla rose almost five times during the period. However, Panasonic maintains a healthy relationship with Tesla. 

Panasonic will use the proceeds to support its future endeavors. According to Nikkei’s previous report, Panasonic will pay $7 billion to acquire Blue Yonder, an AI software developer.

Adidas (OTCMKTS: ADDYY) stock trades at $185.02

Adidas (OTCMKTS: ADDYY) stock closed at $185.02 (up 5.55%) on June 25, 2021. The stock has surged by 7.22% in the past week. 

Investors are advised to exercise caution on Adidas stock. 

Rushnet Inc (OTCMKTS: RSHN) stock trades at $0.0046

Rushnet Inc (OTCMKTS: RSHN) stock closed at $0.0046 on June 25, 2021. The stock is down by 13.21% on volumes of 1 million. 

Rushnet stock lost 61.67% in the past week. Investors can go long on this stock at lower levels.

Enzolytics Inc (OTCMKTS: ENZC) stock trades at $0.20

Enzolytics Inc (OTCMKTS: ENZC) stock closed at $0.20 (up 10.40) on June 25, 2021. It offered swings for intraday traders to enjoy huge profits. The stock gained 69.17% in the past month.

Investors can go long on this stock for a target of $0.30 with a stop loss at $0.16. 

The stock is moving up on posting impressive results. 

Enzolytics successfully concluded clinical trial of Anti-HIV ITV-1 Therapeutic. It is a significant achievement for humanity.

ITV-1 showed effectiveness in curing HIV/AIDS. It also modulates your immune system.

Enzolytics develops and commercializes monoclonal antibodies and proprietary proteins to treat debilitating infectious diseases.

Related Posts

About The Author